|
HUP0201243A3
(en)
*
|
1999-04-30 |
2002-11-28 |
Pfizer Prod Inc |
Glucocorticoid receptor modulators, pharmaceutical compositions containing them and their use
|
|
US6858596B2
(en)
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivative
|
|
US6777399B2
(en)
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
SI1305329T2
(sl)
|
2000-08-05 |
2015-07-31 |
Glaxo Group Limited |
S-fluorometil ester 6alfa,9alfa-difluoro-17alfa-(2-furanilkarboksil)oksi-11beta-hidroksi- 16alfa-metil-3-okso-androst-1,4-dien-17-karbotiojske kisline kot protivnetno sredstvo
|
|
GB0019172D0
(en)
|
2000-08-05 |
2000-09-27 |
Glaxo Group Ltd |
Novel compounds
|
|
IL146057A
(en)
*
|
2000-10-27 |
2007-09-20 |
Pfizer Prod Inc |
A process for the preparation of modulators of a non-steroidal glucocorticoid receptor
|
|
ES2262612T3
(es)
*
|
2000-10-28 |
2006-12-01 |
Pfizer Products Inc. |
Moduladpres del receptor de glucocorticoides.
|
|
DE60113032T2
(de)
|
2000-10-30 |
2006-07-06 |
Pfizer Products Inc., Groton |
Glukokortikoidrezeptor-Modulatoren
|
|
CA2445839A1
(en)
|
2001-04-30 |
2002-11-07 |
Glaxo Group Limited |
Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
|
|
US8193172B2
(en)
|
2001-11-23 |
2012-06-05 |
Pop Test Cortisol Llc |
Methods for the treatment of major depressive disorder using glucocorticoid receptor antagonists
|
|
US20060148725A1
(en)
*
|
2001-12-21 |
2006-07-06 |
The Miriam Hospital |
Selective 11beta HSD inhibitors and methods of use thereof
|
|
AU2002361861A1
(en)
*
|
2001-12-21 |
2003-07-30 |
Rhode Island Hospital |
SELECTIVE 11Beta-HSD INHIBITORS AND METHODS FOR USE THEREOF
|
|
CA2472746A1
(en)
|
2002-01-14 |
2003-07-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof
|
|
DE60318188T2
(de)
|
2002-03-26 |
2008-12-11 |
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield |
Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung
|
|
JP2005521717A
(ja)
|
2002-03-26 |
2005-07-21 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
グルココルチコイドミメチックス、その製造方法、その医薬組成物、及び使用
|
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
US7074806B2
(en)
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
GB2389530B
(en)
|
2002-06-14 |
2007-01-10 |
Cipla Ltd |
Pharmaceutical compositions
|
|
EP1521733B1
(en)
*
|
2002-07-08 |
2014-08-20 |
Pfizer Products Inc. |
Modulators of the glucocorticoid receptor
|
|
WO2004018429A2
(en)
|
2002-08-21 |
2004-03-04 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
KR20050036982A
(ko)
*
|
2002-08-29 |
2005-04-20 |
베링거 인겔하임 파마슈티칼즈, 인코포레이티드 |
염증, 알러지 및 증식성 질환의 치료에 글루코코르티코이드모사체로 사용하기 위한 3-(설폰아미도에틸)-인돌 유도체
|
|
US20040220153A1
(en)
*
|
2002-09-24 |
2004-11-04 |
Jost-Price Edward Roydon |
Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
|
|
AU2003267728A1
(en)
*
|
2002-10-18 |
2004-05-04 |
Pfizer Products Inc. |
Cannabinoid receptor ligands and uses thereof
|
|
CA2504751C
(en)
*
|
2002-11-05 |
2013-02-05 |
Corcept Therapeutics, Inc. |
Methods for treating gastroesophageal reflux disease
|
|
US20060052354A1
(en)
*
|
2002-11-05 |
2006-03-09 |
Corcept Therapeutics, Inc. |
Methods for treating migraine
|
|
EP1583745A1
(en)
|
2003-01-03 |
2005-10-12 |
Boehringer Ingelheim Pharmaceuticals Inc. |
1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
|
|
TW200503994A
(en)
*
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
|
WO2004097002A2
(en)
*
|
2003-04-29 |
2004-11-11 |
The Miriam Hospital |
SELECTIVE TESTICULAR 11β-HSD INHIBITORS AND METHODS OF USE THEREOF
|
|
NZ527142A
(en)
*
|
2003-07-23 |
2006-03-31 |
Douglas Pharmaceuticals Ltd |
A stable suspension formulation
|
|
US8097606B2
(en)
|
2003-07-23 |
2012-01-17 |
Corcept Therapeutics, Inc. |
Antiglucocorticoids for the treatment of catatonia
|
|
UY28526A1
(es)
|
2003-09-24 |
2005-04-29 |
Boehringer Ingelheim Pharma |
Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
|
|
TW200517114A
(en)
|
2003-10-15 |
2005-06-01 |
Combinatorx Inc |
Methods and reagents for the treatment of immunoinflammatory disorders
|
|
EP1675839B1
(en)
|
2003-10-16 |
2007-07-11 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Stereoselective synthesis of certain trifluoromethyl-substituted alcohols
|
|
WO2005047254A1
(en)
*
|
2003-11-13 |
2005-05-26 |
Pfizer Products Inc. |
Octahydrophenanthrene hydrazinde derivatives useful as glucocorticoid receptor modulators
|
|
EP1689390B1
(en)
|
2003-11-21 |
2011-02-09 |
Zalicus Inc. |
Methods and reagents for the treatment of inflammatory disorders
|
|
US7253283B2
(en)
*
|
2004-01-16 |
2007-08-07 |
Bristol-Myers Squibb Company |
Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
|
US7795272B2
(en)
*
|
2004-03-13 |
2010-09-14 |
Boehringer Ingelheim Pharmaceutical, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
|
|
US20050261292A1
(en)
*
|
2004-05-19 |
2005-11-24 |
Solvay Pharmaceuticals Gmbh |
Pharmaceutical composition containing N-sulfamoyl-N'-arylpiperazines for the treatment or inhibition of obesity and related conditions
|
|
US20090156565A1
(en)
*
|
2004-12-03 |
2009-06-18 |
The Children's Hospital Of Philadelphia |
Composition and use thereof in enhancing a therapeutic effect of an antiepileptic drug
|
|
ES2326907T3
(es)
|
2004-12-27 |
2009-10-21 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Mimeticos de glucocorticoides, metodos para su preparacion, composiciones farmaceuticas y su uso.
|
|
TWI435729B
(zh)
|
2005-11-09 |
2014-05-01 |
Combinatorx Inc |
治療病症之方法，組合物及套組
|
|
US7640389B2
(en)
*
|
2006-02-28 |
2009-12-29 |
Freescale Semiconductor, Inc. |
Non-volatile memory having a multiple block erase mode and method therefor
|
|
US20080045475A1
(en)
*
|
2006-08-20 |
2008-02-21 |
Phillip Edward Littmann |
Elemental cellular therapy is a genetic, cellular and disease-modifying therapy which enhances the systemic conduct of genetic and cellular transmethylation activity resulting in enhancement of concerted genetic and cellular metabolic, physiologic and homeostatic processes
|
|
BRPI0720131A2
(pt)
*
|
2006-12-06 |
2014-02-04 |
Boehringer Ingelheim Int |
Glicocorticoides miméticos, métodos para fazê-los, composições farmacêuticas e usos dos mesmos.
|
|
AP2411A
(en)
*
|
2007-02-02 |
2012-05-30 |
Pfizer Prod Inc |
Tricyclic compounds and their use as glucocorticoid receptor modulators
|
|
CA2676670C
(en)
*
|
2007-02-02 |
2012-03-13 |
Pfizer Products Inc. |
Tricyclic compounds, compositions, and methods
|
|
KR20110020902A
(ko)
*
|
2008-06-06 |
2011-03-03 |
베링거 인겔하임 인터내셔날 게엠베하 |
글루코코르티코이드 유사체, 이의 제조방법, 약제학적 조성물 및 이의 용도
|
|
BRPI0917212A2
(pt)
|
2008-07-28 |
2015-11-10 |
Pfizer |
compostos de fenantrenona, seus usos na preparação de composições, e composições compreendendo os referidos compostos
|
|
WO2010021681A2
(en)
*
|
2008-08-18 |
2010-02-25 |
Combinatorx (Singapore) Pte. Ltd. |
Compositions and methods for treatment of viral diseases
|
|
CN101338200B
(zh)
*
|
2008-08-20 |
2011-08-17 |
石家庄国大工业有限公司 |
一种tn型液晶材料的混合物
|
|
US9216221B2
(en)
*
|
2008-11-07 |
2015-12-22 |
University Of Sheffield |
Medicament and method of diagnosis for treating subclinical Cushing's syndrome
|
|
EP2459524A2
(en)
|
2009-07-31 |
2012-06-06 |
Cadila Healthcare Limited |
Novel compounds as modulators of glucocorticoid receptors
|
|
NZ598462A
(en)
|
2009-08-31 |
2012-12-21 |
Merck Sharp & Dohme |
Pyranyl aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
|
|
EP2632892B1
(en)
*
|
2010-10-27 |
2014-07-30 |
SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. |
Diterpenoid derivatives endowed of biological properties
|
|
MX2013010576A
(es)
*
|
2011-03-15 |
2014-03-12 |
Abbvie Inc |
Moduladores de receptores de hormonas nucleares.
|
|
US9573898B2
(en)
|
2011-09-21 |
2017-02-21 |
Givaudan S.A. |
Pyridine derivates and their use as Umami tastants
|
|
TW201422590A
(zh)
|
2012-09-07 |
2014-06-16 |
Abbvie Inc |
雜環核激素受體調節劑
|
|
EP2935284A4
(en)
*
|
2012-12-21 |
2016-04-27 |
Abbvie Inc |
HETEROCYCLIC MODULATORS OF HORMONE NUCLEAR RECEPTORS
|
|
SG11201506796XA
(en)
*
|
2013-03-14 |
2015-09-29 |
Bristol Myers Squibb Co |
Bicyclo [2.2.1] acid gpr120 modulators
|
|
CZ2014575A3
(cs)
*
|
2014-08-26 |
2016-02-24 |
Ústav organické chemie a biochemie AV ČR, v.v.i. |
Amfifilní sloučeniny s neuroprotektivními účinky
|
|
SK592017A3
(sk)
*
|
2017-07-04 |
2019-01-08 |
Saneca Pharmaceuticals A. S. |
Spôsob prípravy morfínanových zlúčenín
|
|
EP3821220B1
(en)
|
2018-08-22 |
2024-11-13 |
University of Utah Research Foundation |
Force and torque sensor for prosthetic and orthopedic devices
|
|
WO2020047043A1
(en)
|
2018-08-28 |
2020-03-05 |
Lenzi Tommaso |
Variable transmission for assistive prosthesis device
|
|
ES2980934T3
(es)
|
2019-01-22 |
2024-10-03 |
Akribes Biomedical Gmbh |
Modificadores selectivos del receptor de glucocorticoides para tratar la cicatrización alterada de heridas en la piel
|
|
US20220288091A1
(en)
*
|
2019-03-18 |
2022-09-15 |
Lynnette K. NIEMAN |
Method for Improving Insulin Sensitivity
|
|
JP7716113B2
(ja)
|
2020-03-20 |
2025-07-31 |
ユニバーシティ オブ ユタ リサーチ ファウンデーション |
受動型および動力付き外骨格における自己整列機構
|